Evidence map›Paper›PMID 25281324›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2014

Biphasic modulation of paracellular claudin-5 expression in mouse brain endothelial cells is mediated through the phosphoinositide-3-kinase/AKT pathway.

Ryan B Camire, Holly J Beaulac, Stephanie A Brule, Annie I McGregor, Emily E Lauria, Colin L Willis

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Claudin-5: gatekeeper of neurological function.Fluids and barriers of the CNS · 2019
    Review
  6. Molecules (Basel, Switzerland) · 2018
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ryan B CamireWestbrook College of Health Professions (R.B.C., E.E.L.), Department of Biomedical Sciences, College of Osteopathic Medicine, and Center for Excellence in the Neurosciences (H.J.B., C.L.W.), and College of Arts and Sciences (S.A.B., A.I.M.), University of New England, Biddeford, Maine.
Holly J BeaulacWestbrook College of Health Professions (R.B.C., E.E.L.), Department of Biomedical Sciences, College of Osteopathic Medicine, and Center for Excellence in the Neurosciences (H.J.B., C.L.W.), and College of Arts and Sciences (S.A.B., A.I.M.), University of New England, Biddeford, Maine.
Stephanie A BruleWestbrook College of Health Professions (R.B.C., E.E.L.), Department of Biomedical Sciences, College of Osteopathic Medicine, and Center for Excellence in the Neurosciences (H.J.B., C.L.W.), and College of Arts and Sciences (S.A.B., A.I.M.), University of New England, Biddeford, Maine.
Annie I McGregorWestbrook College of Health Professions (R.B.C., E.E.L.), Department of Biomedical Sciences, College of Osteopathic Medicine, and Center for Excellence in the Neurosciences (H.J.B., C.L.W.), and College of Arts and Sciences (S.A.B., A.I.M.), University of New England, Biddeford, Maine.
Emily E LauriaWestbrook College of Health Professions (R.B.C., E.E.L.), Department of Biomedical Sciences, College of Osteopathic Medicine, and Center for Excellence in the Neurosciences (H.J.B., C.L.W.), and College of Arts and Sciences (S.A.B., A.I.M.), University of New England, Biddeford, Maine.
Colin L WillisWestbrook College of Health Professions (R.B.C., E.E.L.), Department of Biomedical Sciences, College of Osteopathic Medicine, and Center for Excellence in the Neurosciences (H.J.B., C.L.W.), and College of Arts and Sciences (S.A.B., A.I.M.), University of New England, Biddeford, Maine clwillis@outlook.com.
Florida State University · USUniversity of New England · US

Funding

Tissue resident macrophages in sensory ganglia: function and impact on nociceptionP20GM103643 · NIGMS · UNIVERSITY OF NEW ENGLAND · PI MENG, IAN D · 2012 to 2021
$20.9M
NIGMS NIH HHS P20 GM103643NIGMS NIH HHS P20-GM103643
6 · The paper itself

Abstract

Blood-brain barrier (BBB) integrity is compromised in many central nervous system disorders. Complex astrocyte and vascular endothelial cell interactions that regulate BBB integrity may be disturbed in these disorders. We previously showed that systemic administration of 3-chloropropanediol [(S)-(+)-3-chloro-1,2-propanediol] induces a transitory glial fibrillary acidic protein-astrocyte loss, reversible loss of tight junction complexes, and BBB integrity disruption. However, the intracellular signaling mechanisms that induce BBB integrity marker loss are unclear. We hypothesize that 3-chloropropanediol-induced modulation of tight junction protein expression is mediated through the phosphoinositide-3-kinase (PI3K)/AKT pathway. To test this hypothesis, we used a mouse brain endothelial cell line (bEnd.3) exposed to 3-chloropropanediol for up to 3 days. Results showed early reversible loss of sharp paracellular claudin-5 expression 90, 105, and 120 minutes after 3-chloropropanediol (500 μM) treatment. Sharp paracellular claudin-5 profiles were later restored, but lost again by 2 and 3 days after 3-chloropropanediol treatment. Western blot and immunofluorescence studies showed increased p85-PI3K expression and transitory increased AKT (Thr308) phosphorylation at 15 and 30 minutes after 3-chloropropanediol administration. PI3K inhibitors LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one hydrochloride; 2.5-25 μM] and PI-828 [2-(4-morpholinyl)-8-(4-aminopheny)l-4H-1-benzopyran-4-one; 0.1-10 μM] prevented the 3-chloropropanediol-induced AKT (Thr308) phosphorylation and both early and late loss of paracellular claudin-5. However, AKT inhibitors only prevented the early changes in claudin-5 expression. This mechanistic study provides a greater understanding of the intracellular signaling pathways mediating tight junction protein expression and supports a hypothesis that two independent pathways triggered by PI3K mediate early and late loss of paracellular claudin-5 expression.

Indexed as

AnimalsBlood-Brain BarrierBrainCell Line, TransformedChromonesClaudin-5Endothelial CellsGene Expression RegulationMiceMice, Inbred BALB CMorpholinesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktSignal TransductionTight Junctions2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesClaudin-5Cldn5 protein, mouseMorpholinesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-akt

Identifiers

PMID25281324
PMCPMC4244583
OpenAlexW1991134454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.